The Cooper Companies, Inc. (LON:0I3I)

Market Cap	10.39B
Revenue (ttm)	2.99B
Net Income (ttm)	310.65M
Shares Out	n/a
EPS (ttm)	1.55
PE Ratio	33.43
Forward PE	16.57
Dividend	n/a
Ex-Dividend Date	n/a

Volume	26
Average Volume	2,204
Open	70.68
Previous Close	70.08
Day's Range	70.05 - 70.68
52-Week Range	65.00 - 111.99
Beta	0.99
RSI	41.38
Earnings Date	May 29, 2025

About The Cooper Companies

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia; and spherical lense, including lenses that correct near and farsightedness in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The CooperSurgical segment focuses on family and women’s he...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1958
• Employees: 16,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0I3I

Financial Performance

In 2024, The Cooper Companies's revenue was $3.90 billion, an increase of 8.41% compared to the previous year's $3.59 billion. Earnings were $392.30 million, an increase of 33.34%.

Financial numbers in USD